Mylan sues FDA over Teva's Provigil copy; BMS still eyeing an Amylin buyout, WSJ says;

@FiercePharma: Ranbaxy's knockoff version of Lipitor outsells Pfizer's ($PFE) branded pills, with Watson in distant 3rd place--WSJ. Article | Follow @FiercePharma

> Mylan ($MYL) sued the FDA for giving Teva Pharmaceutical Industries ($TEVA) exclusive rights to sell a generic version of Provigil, after Teva bought the drug's maker, Cephalon, last year. Report

> Bristol-Myers Squibb ($BMY) is still in the hunt for Amylin Pharmaceuticals ($AMLN), sources tell The Wall Street Journal, after its $22-per-share offer was rebuffed. Report

> Par Pharmaceutical said it launched its version of Provigil under license from Teva Pharmaceutical Industries, acquired after antitrust regulators required Teva to sell U.S. rights. Report

> Eli Lilly's ($LLY) imaging agent Amyvid won FDA approval to help doctors detect the brain plaques linked with Alzheimer's disease. Report

> Roche ($RHHBY) said it might consider adding value to its Illumina bid, provided the gene-sequencing company sits down to negotiate a possible deal. Report

> After the U.K.'s cost-effectiveness watchdog rejected its cancer drug Halaven, Eisai inked a deal to co-promote the drug with Valeant Pharmaceuticals' PharmaSwiss division. Report

> The FDA's ban on some agricultural uses of antibiotics went into effect Friday. Report

> Pfizer's heart failure drug Inspra won a new indication in the U.K. to reduce the risk of patients with the heart condition. Report

Biotech News

@FierceBiotech: Optimer Pharma ousts chairman, top execs over a grant of shares in affiliate. News | Follow @FierceBiotech

@JohnCFierce: Lilly's Amyvid OK'd to rule out Alzheimer's, but not to diagnose the disease, which neatly captures the R&D challenge. More | Follow @JohnCFierce

@RyanMFierce: Good piece in @Forbes this morning on India's open source drug discovery unit, where online tools used to find new drugs: Item | Follow @RyanMFierce

> Lilly gains FDA approval for its controversial brain plaque test. News

> Bristol stays in hunt for Amylin. More

> Astellas scores FDA panel nod for overactive bladder drug. Article

Medical Devices News

 @FierceMedDev: Texas Instruments Gift Leads to New Biomedical Device Center | University of Texas at Dallas. Piece | Follow @FierceMedDev

> St. Jude demands retraction of Riata lead study. News

> Doctors overuse invasive heart test, study says. Item

> FDA approves Lilly's brain plaque diagnostic tool. News

> Teleflex launches catheter positioning device in EU. More

IT News

> Gotham's genome center grabs grant for bioinformatics hires. Story

> Radiant Sage finds big software need for Pfizer. Article

> New frontier in digitized clinical trials: Video games? Item

> Roche helps corral diabetes chitchat from Twitter. Story

> Apple emerges as 'dominant' life sciences IT player. More

And Finally... Spain is weighing restrictions on use of its state-run health system by its wealthier citizens. Report